Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GEMCITABINE Cause Diffuse large b-cell lymphoma? 306 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 306 reports of Diffuse large b-cell lymphoma have been filed in association with GEMCITABINE (Gemcitabine). This represents 1.0% of all adverse event reports for GEMCITABINE.

306
Reports of Diffuse large b-cell lymphoma with GEMCITABINE
1.0%
of all GEMCITABINE reports
82
Deaths
39
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma From GEMCITABINE?

Of the 306 reports, 82 (26.8%) resulted in death, 39 (12.7%) required hospitalization, and 34 (11.1%) were considered life-threatening.

Is Diffuse large b-cell lymphoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 306 reports have been filed with the FAERS database.

What Other Side Effects Does GEMCITABINE Cause?

Off label use (3,319) Disease progression (3,123) Thrombocytopenia (2,320) Drug ineffective (2,003) Malignant neoplasm progression (1,962) Neutropenia (1,892) Anaemia (1,745) Pyrexia (1,511) Nausea (1,336) Myelosuppression (1,197)

What Other Drugs Cause Diffuse large b-cell lymphoma?

RITUXIMAB (1,571) CYCLOPHOSPHAMIDE (1,183) PREDNISONE (1,062) METHOTREXATE (1,055) VINCRISTINE (1,043) DOXORUBICIN (1,002) LENALIDOMIDE (779) TACROLIMUS (595) DEXAMETHASONE (539) PREDNISOLONE (506)

Which GEMCITABINE Alternatives Have Lower Diffuse large b-cell lymphoma Risk?

GEMCITABINE vs GEMCITABINE\GEMCITABINE GEMCITABINE vs GEMFIBROZIL GEMCITABINE vs GEMTUZUMAB OZOGAMICIN GEMCITABINE vs GEMZAR GEMCITABINE vs GENTAMICIN

Related Pages

GEMCITABINE Full Profile All Diffuse large b-cell lymphoma Reports All Drugs Causing Diffuse large b-cell lymphoma GEMCITABINE Demographics